Evidence map›Paper›PMID 33928439›Full record

SynthesisPediatric nephrology (Berlin, Germany)2021

Critical analysis of acute kidney injury in pediatric COVID-19 patients in the intensive care unit.

Rupesh Raina, Ronith Chakraborty, Isabelle Mawby, Nirav Agarwal, Sidharth Sethi, Michael Forbes

Registry-linked trialOpen access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in Pediatric nephrology (Berlin, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05582512 (Clinical Characteristics and Long Term Impact on Pediatric COVID-19 in Taiwan), which is not on this map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05582512 recruitingnot on this mapstarted 2022, after this paper: background citation

Clinical Characteristics and Long Term Impact on Pediatric COVID-19 in Taiwan

Typeobservational_patient_registrySponsorNational Taiwan University HospitalRan2022 to 2027Enrolled3,000ConditionsLong Covid19, COVID-19 Pneumonia, Multisystem Inflammatory Syndrome in ChildrenArmssequelae tracking
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Acute kidney injury: a post-COVID-19 complication in children and adolescents.Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Rupesh RainaDepartment of Nephrology, Akron Nephrology Associates/Cleveland Clinic Akron General, Akron, OH, USA. rraina@akronchildrens.org.ORCID 0000-0003-3892-8376
Ronith ChakrabortyDepartment of Nephrology, Akron Nephrology Associates/Cleveland Clinic Akron General, Akron, OH, USA.
Isabelle MawbyDepartment of Nephrology, Akron Nephrology Associates/Cleveland Clinic Akron General, Akron, OH, USA.
Nirav AgarwalDepartment of Nephrology, Akron Nephrology Associates/Cleveland Clinic Akron General, Akron, OH, USA.
Sidharth SethiPediatric Nephrology, Kidney Institute, Medanta, The Medicity Hospital, Gurgaon, Haryana, India.
Michael ForbesDirector of Clinical Research and Outcomes Analysis, Department of Pediatrics, Akron Children's Hospital, Akron, OH, USA.
Cleveland Clinic · USAkron Children's Hospital · USMedanta The Medicity · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesCOVID-19 is responsible for the 2019 novel coronavirus disease pandemic. Despite the vast research about the adult population, there has been little data collected on acute kidney injury (AKI) epidemiology, associated risk factors, treatments, and mortality in pediatric COVID-19 patients admitted to the ICU. AKI is a severe complication of COVID-19 among children and adolescents.

methodsA comprehensive literature search was conducted in PubMed/MEDLINE and Cochrane Center Trials to find all published literature related to AKI in COVID-19 patients, including incidence and outcomes.

resultsTwenty-four studies reporting the outcomes of interest were included. Across all studies, the overall sample size of COVID positive children was 1,247 and the median age of this population was 9.1 years old. Among COVID positive pediatric patients, there was an AKI incidence of 30.51%, with only 0.56% of these patients receiving KRT. The mortality was 2.55% among all COVID positive pediatric patients. The incidence of multisystem inflammatory syndrome in children (MIS-C) among COVID positive patients was 74.29%.

conclusionAKI has shown to be a negative prognostic factor in adult patients with COVID-19 and now also in the pediatric cohort with high incidence and mortality rates. Additionally, our findings show a strong comparison in epidemiology between adult and pediatric COVID-19 patients; however, they need to be confirmed with additional data and studies.

Indexed as

Acute Kidney InjuryAdultAge FactorsChildCOVID-19Hospital MortalityHumansIncidenceIntensive Care UnitsPandemicsRenal Replacement TherapyRisk FactorsSARS-CoV-2Systemic Inflammatory Response SyndromeAcute kidney injuryAdultCOVID-19Kidney replacement therapyMIS-CPediatric

Identifiers

PMID33928439
PMCPMC8083920
OpenAlexW3158039969

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.